HPRA MIMS Articles October 2018

Notice type: 3rd Party Publications

Date: 13/12/2019

 Ocaliva (obeticholic acid): Risk of serious liver injury in patients with pre-existing moderate or severe hepatic impairment – reminder of differential dosing recommendations
HPRA MIMS main book article October 2018 - Ocaliva

 Valproate (Epilim): New contraindications, strengthened warnings and measures to prevent exposure during pregnancy
HPRA MIMS Women's Health supp. October 2018 - Valproate

 Clarithromycin: Reminder on cardiovascular safety and risk minimisation advice
HPRA MIMS Resp Supp October 2018 - Clarithromycin

« Back